CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3014% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health Peer Benchmark by Year
Peer Benchmark — HCA Healthcare (HCA) & Labcorp (LH): Provider & Lab Revenues ($M)
Cvs Health Peer Benchmark: $75,600M in FY2025, up 7.1% from a year earlier.
Latest, FY2025
75,600
Period ended Dec 31, 2025
Change on a year earlier
+7.1%
70,603 in FY2024
History
7 years
Since FY2019
Sources
1
HCA Healthcare, Inc. SEC 10-K (XBRL)
Where the FY2025 figure comes from
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Peer Benchmark — HCA Healthcare (HCA) & Labcorp (LH): Provider & Lab Revenues ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 75,600 | +7.1% | HCA Healthcare, Inc. SEC 10-K (XBRL) ↗ |
| FY2024 | Dec 31, 2024 | 70,603 | +8.7% | HCA Healthcare, Inc. SEC 10-K (XBRL) ↗ |
| FY2023 | Dec 31, 2023 | 64,968 | +7.9% | HCA Healthcare, Inc. SEC 10-K (XBRL) ↗ |
| FY2022 | Dec 31, 2022 | 60,233 | +2.5% | HCA Healthcare, Inc. SEC 10-K (XBRL) ↗ |
| FY2021 | Dec 31, 2021 | 58,752 | +14.0% | HCA Healthcare, Inc. SEC 10-K (XBRL) ↗ |
| FY2020 | Dec 31, 2020 | 51,533 | +0.4% | HCA Healthcare, Inc. SEC 10-K (XBRL) ↗ |
| FY2019 | Dec 31, 2019 | 51,336 | – | HCA Healthcare, Inc. SEC 10-K (XBRL) ↗ |
Breakdown
What makes up peer Benchmark
Cite this data
StockData. (2026). Cvs Health Peer Benchmark ($M), annual FY2019–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer-hca-revenue
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.